Intro

This chapter discusses the study of CM313, a novel anti-CD38 monoclonal antibody for treating ITP, and the success in achieving primary efficacy outcomes. It also briefly covers a rare intestine transplant for a woman with mesenteric ischemia.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app